Patents
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
05/2005
05/12/2005CA2541856A1 Modified polypeptides with therapeutic activity and methods of use
05/11/2005EP1529843A2 Novel secreted proteins and their uses
05/11/2005EP1529839A1 Mutant phosphoribosylpyrophosphate synthetase and method for producing L-histidine
05/11/2005EP1529766A1 Process for fragmentation of fungal, bacterial or yeast cell DNA and for inactivating residual antibiotics in fermentation biomass
05/11/2005EP1529114A1 Process for preparing peptides with anti-hypertensive properties
05/11/2005EP1529109A2 Production of multimeric fusion proteins using a c4bp scaffold
05/11/2005EP1529108A2 Albumin-fused ciliary neurotrophic factor
05/11/2005EP1529064A2 Heteropolymeric compound comprising a scaffold, an adjuvant and an antigen, and its use
05/11/2005EP1529059A2 Porcine leptin protein, antisense and antibody
05/11/2005EP1529055A2 Isolated nucleic acid molecule encoding a novel centromere-associated motor protein, and uses thereof
05/11/2005EP1529054A2 Therapeutic protein and treatments
05/11/2005EP1088069B1 Angiostatin-binding protein
05/11/2005EP1070117B1 Genetic constructs and genetically modified microbes for enhanced production of beta-glucosidase
05/11/2005EP1062364B1 Qualitative differential screening
05/11/2005EP0944725B1 Phosphodiesterase 8
05/11/2005EP0730606B1 Hu-B1.219, A NOVEL HUMAN HEMATOPOIETIN RECEPTOR
05/11/2005EP0625200B1 Biosynthetic binding protein for cancer marker
05/11/2005CN1615362A Gene promoters
05/11/2005CN1615360A Process for producing l-amino acid using escherichia
05/11/2005CN1615359A Process for producing l-amino acid using escherichia
05/11/2005CN1615150A Assay for the detection of factors that modulate the expression of INGAP
05/11/2005CN1614025A Method and use of producing soluble recombinant protein in colibacillus
05/11/2005CN1614016A Production of human interleukin 288 and recombined IL-288 engineering bacteria
05/11/2005CN1614015A Xylanase, production and special producing strain thereof
05/11/2005CN1614013A Separation and purification of 1, 6-glycidyl-beta-D pyranglucokinase and its gene sequence
05/11/2005CN1614009A Bacterial breaking of TPA derivative by gene engineering technology
05/11/2005CN1614008A Recombinant corynebacterium glutamicum, construction and use thereof
05/11/2005CN1614007A Gluconobacter and its use
05/11/2005CN1614006A Thermophilic denitrifying bacillocin, screening and use thereof
05/11/2005CN1614005A Production of easily fragile solid culture of bacillus thuringiensis for biological agro-chemicals
05/11/2005CN1614004A Constructing method for candida tropicalis gene engineering recombinant bacterium
05/11/2005CN1614003A Culture of Chansi mould strains and extraction and use of anagentic compound therefrom
05/11/2005CN1614002A Spove culture of tobacco mould
05/11/2005CN1614001A Serial production for industrial waste gas purifying bacterium
05/11/2005CN1613872A Interferon of IFN-beta-cn and its mutant
05/11/2005CN1201008C Yeast strains with interrupted ATF2 gene and use
05/11/2005CN1201006C High-affinity interleukin-4 muteins
05/11/2005CN1201003C Adipocyte-specific protein homologs
05/11/2005CN1201000C Cellulose decomposition bacteria and preparation and use thereof
05/10/2005US6891085 Nucleotidesequences coding polypeptide associated with the generation of disease resistant plants
05/10/2005US6891028 Nucleic acids encoding transferrin receptor-like proteins
05/10/2005US6891023 Antibodies and Fv fragment recognizing antigen IOR C2
05/10/2005US6890902 Cytotoxic modified lactoferrin peptides
05/10/2005US6890752 Synthases
05/10/2005US6890751 NRG-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
05/10/2005US6890746 Gene participating in the production of homo-glutamic acid and utilization thereof
05/10/2005US6890744 Nucleotide sequences coding transcription factor for use in generation of lysine for use in animal nutrients the foods
05/10/2005US6890738 Prolactin antagonists and uses thereof
05/10/2005US6890735 TSG-like gene
05/10/2005US6890731 For drug screeing/therapy of diseases; bacteriophages
05/10/2005US6890720 Antigens derived from filaggrin and their use for diagnosing rheumatoid polyarthritis
05/10/2005US6890717 For diagnostics/screening assays/hybridization probes/primers/therapy for osteoporosis/periodontal disease
05/10/2005US6890710 For treating influenza infections in vivo; fusion proteins; solid phase synthesis
05/10/2005US6890545 Fungicide and method for producing the same
05/10/2005US6890539 Peptide encoded by gene identified herein as pho2-2, obtainable from Group B Streptococcus, or a homologue or a functional fragment thereof; neonatal infections, urinary tract infections
05/10/2005US6890532 Postexposure prophylaxis therapy
05/10/2005US6890529 Edible foods, functional products or pharmaceuticals; nutraceutical; beverages
05/10/2005US6890515 Non-invasive localization of a light-emitting conjugate in a mammal
05/10/2005CA2487530A1 Method and device for targeted delivery of materials to selected single cells
05/10/2005CA2123579C Recombinant multivalent m protein vaccine
05/10/2005CA2118518C Over expression of single-stranded molecules
05/10/2005CA1341482C Process for preparing fragments of aids-associated retroviruses
05/06/2005WO2005040751A2 Decontamination and concentration kit for mycobacteria
05/06/2005WO2005040428A2 Detection of mutations in a gene associated with resistance to viral infection, oas1
05/06/2005WO2005040393A1 Process for preparing enantiomer-enriched alpha-hydroxycarboxylic acids and amides
05/06/2005WO2005040380A1 Rodent immune response regulatory proteins
05/06/2005WO2005040359A1 Vaccine for periodontal disease
05/06/2005WO2005039500A2 METHOD FOR THE PRODUCTION OF BIOACTIVE SUBSTANCES FROM THE NOVEL ACTINOMYCETE TAXON MAR2 (“Marinophilus”)
05/06/2005WO2005021031A3 Live attenuated bacterial vaccine
05/06/2005WO2005014848A3 IMPROVED ELECTROPHYSIOLOGICAL ASSAYS USING OOCYTES THAT EXPRESS HUMAN ENaC AND THE USE OF PHENAMIL TO IMPROVE THE EFFECT OF ENaC ENHANCERS IN ASSAYS USING MEMBRANE POTENTIAL REPORTING DYES
05/06/2005WO2004110933A3 Dehalococcoides isolate for bioremediation
05/06/2005WO2004099381A3 Genetically modified yeast species and fermentation processes using genetically modified yeast
05/06/2005WO2004094644A3 Vibrio cholerae proteins expressed during infection
05/06/2005WO2004083442A3 A method for enhancing levels of polyunsaturated fatty acids in thraustochytrid protists
05/06/2005WO2004078949A3 Genes of an otitis media isolate of nontypeable haemophilus influenzae
05/06/2005WO2004078776A3 Ny-eso-1 peptides which bind to class ii molecules and uses thereof
05/06/2005WO2004037979A3 Improved sso7-polymerase conjugate proteins
05/06/2005WO2004018619A3 P53 binding t cell receptor molecules and uses thereof
05/06/2005WO2003068146A3 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases
05/06/2005CA2546737A1 Method for the production of bioactive substances from the novel actinomycete taxon mar2 ("marinophilus")
05/06/2005CA2543789A1 Detection of mutations in a gene associated with resistance to viral infection, oas1
05/06/2005CA2542221A1 Vaccine for periodontal disease
05/06/2005CA2541864A1 Process for preparing enantiomer-enriched alpha-hydroxycarboxylic acids and amides
05/05/2005US20050097635 Nucleotide sequences coding crystal protein for use in generating insect resistant crop plants; biological pest control
05/05/2005US20050096458 GENSET polynucleotides and polypeptides used as reagents in forensic analyses, as chromosome markers, as tissue/cell/organelle-specific markers, expression vectors production; screening/diagnosis assays for abnormal GENSET expression and/or biological activity; gene therapy; genomics
05/05/2005US20050096457 Peptide substrates and fusion polypeptide substrates comprising a beta -secretase cleavage site wherein a human Aspartyl protease cleaves the peptide between P1 and P1, the rate of which cleavage is used to identify modulators of Alzeimer's disease, neurofibrillary tangles, gliosis and neuronal loss
05/05/2005US20050096277 Methods of prevention and treatment using apolipoprotein analogues
05/05/2005US20050096229 Biocidal compounds and their preparation
05/05/2005US20050095694 Biological method for removing organic polymers
05/05/2005US20050095693 Selected nucleotide sequences isolated from pathogenic strains of haemophilus influenzae
05/05/2005US20050095691 Muant acid phosphatase/phytase for use in enhancement nutrient quality and digestibility of animal feeds
05/05/2005US20050095689 Plant protein for use in enhancing ability to absorb insoluble iron in soils and for improving resistance to iron deficiency in plants
05/05/2005US20050095688 Process for the preparation of L-amino acids using strains of the family Enterobacteriaceae
05/05/2005US20050095687 Process for the preparation of L-amino acids using strains of the family enterobacteriaceae
05/05/2005US20050095683 Bacillus serine proteases for use as active agent in cleaning compounds and detergents
05/05/2005US20050095682 Campylobacter polypeptides and methods of use
05/05/2005US20050095681 Intracellular modulators of apoptopic cell death pathways
05/05/2005US20050095680 Using modified escherichia comprising enhanced carbamoyl-phosphate synthetase activity as a bioreactor for fermentation of arginine for use in medicines, animal feed and cosmetics
05/05/2005US20050095679 Using bacillus as bioreactor for fermentation of high molecular weight poly-gamma-glutamic acid (PGA) for use as constituent in medicine and foods
05/05/2005US20050095670 Low-substrate-specific racemase for use in producing racemates of various amino acids